eFFECTOR Therapeutics, Inc.
NASDAQ:EFTR
0.04 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 3.553 | 1.43 | 42 | 0 |
| Cost of Revenue
| 0.111 | 0.053 | 0.024 | 21.832 | 0.307 |
| Gross Profit
| -0.111 | 3.5 | 1.406 | 20.168 | -0.307 |
| Gross Profit Ratio
| 0 | 0.985 | 0.983 | 0.48 | 0 |
| Reseach & Development Expenses
| 22.808 | 23.313 | 19.956 | 21.832 | 23.583 |
| General & Administrative Expenses
| 10.925 | 12.643 | 13.371 | 4.349 | 4.715 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.925 | 12.643 | 13.371 | 4.349 | 4.715 |
| Other Expenses
| 0 | -3.553 | -1.43 | 0.009 | 0 |
| Operating Expenses
| 33.733 | 32.403 | 31.897 | 26.181 | 28.298 |
| Operating Income
| -33.844 | -32.403 | -31.897 | 15.819 | -28.605 |
| Operating Income Ratio
| 0 | -9.12 | -22.306 | 0.377 | 0 |
| Total Other Income Expenses Net
| -1.967 | 9.738 | 47.695 | -1.257 | -1.134 |
| Income Before Tax
| -35.811 | -22.665 | 15.798 | 14.562 | -29.739 |
| Income Before Tax Ratio
| 0 | -6.379 | 11.048 | 0.347 | 0 |
| Income Tax Expense
| 0 | -9.738 | -0.024 | 0.351 | 0.135 |
| Net Income
| -35.811 | -12.927 | 15.798 | 14.211 | -29.739 |
| Net Income Ratio
| 0 | -3.638 | 11.048 | 0.338 | 0 |
| EPS
| -16.37 | -7.85 | 9.78 | 23.74 | -53.83 |
| EPS Diluted
| -16.37 | -7.85 | 9.78 | 23.74 | -53.83 |
| EBITDA
| -33.733 | -32.403 | -31.897 | 16.055 | -28.298 |
| EBITDA Ratio
| 0 | -9.12 | -22.306 | 0.382 | 0 |